What is Brinzolamide/Brimonidine Tartrate?

Category: Prescription Drugs

Most popular types: Simbrinza

false

Brinzolamide/brimonidine tartrate is the generic form of Simbrinza™. It is an eye-drop intended to lower intraocular pressure in patients with glaucoma or ocular hypertension.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 0
Moderate 0
Mild 0
None 2

Commonly reported side effects and conditions associated with Brinzolamide/Brimonidine Tartrate

Side effect Patients

Dosages

Based on patients currently taking Brinzolamide/Brimonidine Tartrate

Dosage Patients
0.2-1% twice daily 3
0.2-1% daily 1
1 drop(s) twice daily 1

Why patients stopped taking Brinzolamide/Brimonidine Tartrate

Multiple reasons could be selected

Reason Patients
Doctor's advice 1
See 1 patient who's stopped taking Brinzolamide/Brimonidine Tartrate

Duration

Currently taking Brinzolamide/Brimonidine Tartrate

Duration Patients
6 months - 1 year 1
1 - 2 years 1
2 - 5 years 1
5 - 10 years 2

Stopped taking Brinzolamide/Brimonidine Tartrate

Duration Patients
2 - 5 years 1
Adherence
Adherence Evaluations
Always 1
Usually 0
Sometimes 1
Never taken as prescribed 0
Burden
Burden Evaluations
Very hard to take 0
Somewhat hard to take 1
A little hard to take 1
Not at all hard to take 0
Cost per month
Cost per month Evaluations
$200+ 0
$100-199 0
$50-99 0
$25-49 1
< $25 0
Not specified 1

What people switch to and from

Patients started taking Brinzolamide/Brimonidine Tartrate after stopping:

Treatment Patients
Brimonidine ophthalmic (Alphagan Eye Drops) 1
Dorzolamide-timolol (Cosopt) 1
Latanoprost ophthalmic (Xalatan) 1
Travoprost (Travatan Z) 1

Patients stopped taking Brinzolamide/Brimonidine Tartrate and switched to:

Treatment Patients
Latanoprost ophthalmic (Xalatan) 1
Last updated:
There are no evaluations for Brinzolamide/Brimonidine Tartrate.